Scholarlink

<p>Diabetic kidney disease (DKD) is a serious microvascular complication of diabetes, with symptoms of progressive kidney dysfunction, proteinuria, and fibrosis, ultimately causing end-stage renal disease. Mesenchymal stem cells (MSCs) represent a promising therapeutic approach for DKD, primarily through their paracrine effects. In this review, we concluded the mechanism of MSCs in treating DKD, including the inhibition of inflammation, fibrosis, oxidative stress, and modulate vascular endothelial growth factor (VEGF). Additionally, we discuss strategies to enhance MSC efficacy, such as preconditioning, genetic engineering, and combination therapies with pharmacological agents. Furthermore, we provide an overview of completed clinical trials assessing the effectiveness and safety of MSCs transplantation in DKD patients. The purpose of this review is to highlight the MSCs’ potential as an innovative treatment for DKD and to guide future research toward optimizing their therapeutic applications, ultimately improving DKD patients’ quality of life.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Mechanism of mesenchymal stem cells in treating diabetic kidney disease

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月11日

查看全文
  • Lingqian Zheng,
  • Wenmin Chen,
  • Kaijin Yao,
  • Yongda Lin,
  • Chunling Liao,
  • Tianbiao Zhou

摘要

Diabetic kidney disease (DKD) is a serious microvascular complication of diabetes, with symptoms of progressive kidney dysfunction, proteinuria, and fibrosis, ultimately causing end-stage renal disease. Mesenchymal stem cells (MSCs) represent a promising therapeutic approach for DKD, primarily through their paracrine effects. In this review, we concluded the mechanism of MSCs in treating DKD, including the inhibition of inflammation, fibrosis, oxidative stress, and modulate vascular endothelial growth factor (VEGF). Additionally, we discuss strategies to enhance MSC efficacy, such as preconditioning, genetic engineering, and combination therapies with pharmacological agents. Furthermore, we provide an overview of completed clinical trials assessing the effectiveness and safety of MSCs transplantation in DKD patients. The purpose of this review is to highlight the MSCs’ potential as an innovative treatment for DKD and to guide future research toward optimizing their therapeutic applications, ultimately improving DKD patients’ quality of life.